NSCLC tissue; adjacent normal lung tissue; cancer tissues; matched normal lung tissues
PC9; H1573; A549; SK-MES-1; H1299; Calu-3; HEK-293T
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); apoptosis (inhibits)
RT-qPCR; Clinical Sample Validation; Cohort Study; Survival Analysis; Transfection; CCK8; Annexin V/PI Flow Cytometry; Western Blot; Transwell Assay; In Vivo Animal Model; H&E Staining; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Microarray; Bioinformatics Analysis
Up-regulation of hsa_circ_0020123 is associated with poor differentiation degree, lymph node metastasis, high TNM stage and poor prognosis; it may serve as a prognosis predictor and therapeutic target for NSCLC.
hsa_circ_0020123 is up-regulated in NSCLC tissues and is associated with advanced clinicopathological features and poor overall survival. Functionally, it promotes NSCLC proliferation, migration, invasion, tumor growth and metastasis and inhibits apoptosis. Mechanistically, it sponges miR-144 to increase ZEB1 and EZH2 expression, forming a hsa_circ_0020123-miR-144-ZEB1/EZH2 ceRNA axis.
0.798
A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.
combined biological and clinical study